NCT05895864View on ClinicalTrials.gov

Utidelone Treated for the Recurrent or Metastatic Urothelial Carcinoma

PHASE2RecruitingINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

June 7, 2023

Primary Completion Date

December 31, 2024

Study Completion Date

December 13, 2025

Conditions
Metastatic Urothelial Carcinoma
Interventions
DRUG

utidelone injection

utidelone monotherapy in patients with recurrent or metastatic urothelial carcinoma by utidelone

Trial Locations (1)

510120

RECRUITING

Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou

All Listed Sponsors
lead

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

OTHER